다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Standard BioTools Inc (LAB)
Standard BioTools Inc (LAB) 뉴스

LAB

Standard BioTools (LAB)

Standard BioTools Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:LAB

1 2 3 4 5 6 7 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/17	10:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/05/11	06:16	Edgar (US Regulatory)	Form PREC14A - Preliminary proxy statements, contested solicitations	NASDAQ:LAB	Standard BioTools Inc
2024/05/10	05:53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:LAB	Standard BioTools Inc
2024/05/09	05:31	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LAB	Standard BioTools Inc
2024/05/09	05:01	GlobeNewswire Inc.	Standard BioTools Reports First Quarter 2024 Financial Results	NASDAQ:LAB	Standard BioTools Inc
2024/04/25	21:01	GlobeNewswire Inc.	Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth	NASDAQ:LAB	Standard BioTools Inc
2024/04/25	21:00	GlobeNewswire Inc.	Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024	NASDAQ:LAB	Standard BioTools Inc
2024/04/08	21:00	GlobeNewswire Inc.	Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue Imaging	NASDAQ:LAB	Standard BioTools Inc
2024/04/04	05:01	GlobeNewswire Inc.	Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine Research	NASDAQ:LAB	Standard BioTools Inc
2024/03/18	21:12	GlobeNewswire Inc.	Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common Stock	NASDAQ:LAB	Standard BioTools Inc
2024/03/07	09:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/02/29	06:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:LAB	Standard BioTools Inc
2024/02/29	06:01	GlobeNewswire Inc.	Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:LAB	Standard BioTools Inc
2024/02/27	06:15	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:LAB	Standard BioTools Inc
2024/02/26	22:00	GlobeNewswire Inc.	Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen Sequencing	NASDAQ:LAB	Standard BioTools Inc
2024/02/23	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc
2024/02/23	06:05	GlobeNewswire Inc.	Standard BioTools to Participate in Upcoming Investor Conferences	NASDAQ:LAB	Standard BioTools Inc
2024/02/15	05:32	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:LAB	Standard BioTools Inc
2024/02/14	22:30	GlobeNewswire Inc.	Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	NASDAQ:LAB	Standard BioTools Inc
2024/02/08	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LAB	Standard BioTools Inc
2024/02/08	14:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LAB	Standard BioTools Inc
2024/02/07	22:30	GlobeNewswire Inc.	Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized Medicine	NASDAQ:LAB	Standard BioTools Inc
2024/02/03	06:49	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:LAB	Standard BioTools Inc
2024/01/20	07:07	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:LAB	Standard BioTools Inc
2024/01/20	07:05	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:LAB	Standard BioTools Inc
2024/01/20	07:03	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LAB	Standard BioTools Inc
2024/01/20	06:48	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:LAB	Standard BioTools Inc
2024/01/20	06:33	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:LAB	Standard BioTools Inc
2024/01/13	04:04	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:LAB	Standard BioTools Inc
2024/01/10	10:51	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LAB	Standard BioTools Inc

검색 관련기사 보기:NASDAQ:LAB

1 2 3 4 5 6 7 다음 >>

Gold vs US Dollar

Energy Select Sector SPDR

US Dollar vs Euro

American Express

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관